Navigation Links
OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Date:7/11/2012

SAN DIEGO, July 11, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110). UCSF investigators are actively recruiting patients for this clinical trial. OMS-I110 was initiated at the University of Washington in January 2012, and the first patient was dosed there on January 6, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

A total of up to 15 patients with local and distant Merkel cell carcinoma will be enrolled in this Phase II, single-arm, open-label multi-center study. The trial's primary endpoint is to assess the clinical and biologic effects of increased local expression of interleukin-12 (IL-12) protein in the tumor microenvironment following treatment with OMS ElectroImmunotherapy from baseline to two to four weeks after the first injection. It is anticipated that marked local expression of IL-12 in the tumor will induce an immunologic response in the tumor microenvironment, which may result in clinical benefit for the patient. Investigators at the University of Washington have received Investigational Review Board (IRB) approval and will continue recruitment for this clinical trial as the lead enrollment center.

"We are pleased to have established a clinical site at UCSF for our Merkel cell carcinoma trial that joins our previously established site at the University of Washington," said Punit Dhillon, President and CEO of OncoSec. "We are excited to be working with Dr. Siegrid Yu and UCSF in this Merkel cell carcinoma study. This is the third clinical trial conducted at this academic institution, which includes our ongoi
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
4. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
5. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
6. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
7. ERT Acquires invivodata to Establish the Industrys Most Experienced Provider of Clinical Outcome Assessment Solutions
8. Clinical Study: Dietary Supplement SagaPro Reduces Frequent Urination
9. Mindray Medical to Present at AACC Clinical Lab Expo 2012
10. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
11. Clinical Chemistry Market Report & Forecast (2012 - 2015): Global Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 RadiologyAuction will have ... live video and product demonstrations at the end of ... equipment such as Kodak and Fuji Cr,s, Agfa and ... at the first event. Various imaging equipment will be ... . After years of buying and selling ...
(Date:5/4/2015)... DOYLESTOWN, Pa. , May 4, 2015  Makindus, ... announced today that the European Medicines Agency (EMA) has ... for the treatment of Stargardt,s Disease. "We ... for MI-100 to treat Stargardt,s disease in place for ... our development program in the United States ...
(Date:5/4/2015)... 2015   HeartWare International, Inc . (NASDAQ: HTWR ... technologies that are revolutionizing the treatment of advanced heart failure, ... is scheduled to present at the Bank of America Merrill ... on Thursday, May 14, 2015, at 10:00 a.m. ... the Company,s presentation at the conference will be available via ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2
... Pharmaceuticals Corporation (the "Company") (OTCQX:RXPC), a developer and marketer ... cancer test, announced that all of the holders of ... compelled by the terms thereof, for 50,000 shares of ... the aggregate. The aggregate exercise price for all of ...
... SILVER SPRING, Md., Nov. 30, 2011 The U.S. ... version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets). ... Ranbaxy Laboratories Ltd. has gained approval to make generic ... mg, and 80 mg strengths. The drug will be ...
Cached Medicine Technology:Radient Pharmaceuticals Corporation Receives $500,000 in New Capital 2Radient Pharmaceuticals Corporation Receives $500,000 in New Capital 3FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 2FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor 3
(Date:5/4/2015)... 2015 Ticket Down is a reputable source ... Arena in Columbia, South Carolina. Fans of Paul ... “Out There” tour which originally kicked off in 2013. The ... America and the legendary performer recently announced that he would ... Arena on June 21st, in Charlottesville, VA at John Paul ...
(Date:5/4/2015)... CCL, a top-ranked, global provider of leadership ... other leadership development consultancies. “The CCL Partner Network ... practitioners, expanding our capacity to drive results for individual ... Ryan, CCL President and CEO. , As soon as ... , it will schedule a one-on-one conference with a ...
(Date:5/4/2015)... 04, 2015 San Diego Fertility ... at their brand new, 13,700 square foot facility scheduled ... building will not only provide fertility treatment and services ... offer community and educational events to a number of ... located next door to their current Carmel Valley/Del Mar ...
(Date:5/4/2015)... 2015 Dr. Benjamin Stong of Kalos ... the latest non-surgical double-chin eliminator. Dr. Stong is ... in Atlanta to offer Kybella treatments . The ... specifically under the chin, promising to safely dissolve fat ... patients who sought immediate solutions for their double chin ...
(Date:5/4/2015)... Unlike some camps, the Nike Middle School Running Camps are ... to educate first and train second, with a significant amount of ... runners are building the knowledge base needed to have a long ... include Effort Based Training, Running Heroes, Running Vocabulary, and Why am ... is not a camp where kids come to run and train ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2
... URBANA Could preventing colon cancer be as simple as ... University of Illinois study, scientists showed that human colon cancer ... of bioactive compounds present in one cup of this brew, ... medicinal properties. "The caffeine derivatives in mate tea not ...
... of Nebraska-Lincoln will lead a $25 million project to reduce ... coli strains that pose a major threat to public ... Food and Agriculture announced the grant at UNL on Monday, ... coli , or STEC, which cause more than 265,000 illnesses ...
... -- A Kansas State University professor is turning to nutrition ... human nutrition, is helping men make more informed diet decisions ... risk of prostate cancer. Prostate cancer is one of the ... States. "I,m interested in researching ways to prevent prostate ...
... regions of the genome associated with the timing of menopause. ... reproductive lifespan and will provide insights into conditions connected to ... Menopause is a major hormonal change that affects most ... of menopause can have a huge impact on fertility, as ...
... , FRIDAY, Jan. 20 (HealthDay News) -- The number of ... definition of the disorder is adopted by mental health experts ... of the changes will be, but they agree there will ... and the professionals who treat them. The changes could affect ...
... in younger patients treated for breast cancer is seriously ... infertility, premature menopause, a decrease in physical activity and ... UCLA,s Jonsson Comprehensive Cancer Center. , The study, published ... Institute , found that the mental issues faced by ...
Cached Medicine News:Health News:Compounds in mate tea induce death in colon cancer cells 2Health News:U. of Nebraska to lead $25 million project targeting E. coli threat 2Health News:U. of Nebraska to lead $25 million project targeting E. coli threat 3Health News:Eating smart: Researcher studies foods, dietary supplements that may reduce risk of prostate cancer 2Health News:Genes and timing of menopause 2Health News:Experts Weigh Changes to Definition of Autism 2Health News:Experts Weigh Changes to Definition of Autism 3Health News:Quality of life for younger breast cancer patients more adversely affected than older women 2Health News:Quality of life for younger breast cancer patients more adversely affected than older women 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: